Swedish has suspended the use of Moderna’s COVID-19 vaccine for those aged 30 and under, while Denmark has done the same for those under 18, with both countries saying the move is made out of the utmost precaution and based on a Nordic study.

The study indicated a potential small increase in the risk of myocarditis and pericarditis among youth and young adults with the Moderna vaccine.

“The increase in risk is seen within four weeks after the vaccination, mainly within the first two weeks,” the Swedish Public Health agency said.

Anders Tegnell, Sweden’s chief epidemiologist, said the nation would “follow the situation closely and act quickly to ensure that vaccinations against COVID-19 are always as safe as possible and at the same time provide effective protection.”

The Swedish agency said Pfizer’s vaccine is now the recommended vaccine for these age groups instead. Its decision to suspend the Moderna vaccine is valid until December 1.

Sweden has previously suspended the use of the AstraZeneca vaccine after concerns about a rare link to blood clotting.

The decision to suspend Moderna vaccines for people 30 and under will last until December 1.(

ABC News: Stephen Cavanagh

)

In July, the European Medicines Agency recommended authorising Moderna’s COVID-19 vaccine for children aged 12-17, the first time the shot has been authorised for people under 18.

Denmark also announces pause

In Denmark, people under the age of 18 won’t be offered the Moderna vaccine out of precaution, the Danish Health Authority said on Wednesday.

It said that data, collected from the Nordic study shows that there is a suspicion of an increased risk of heart inflammation when vaccinated with Moderna shots, although the number of cases remains very low.

The preliminary data from the Nordic study has been sent to the European Medicines Agency’s adverse reaction committee and will now be assessed.

The study was conducted by Denmark’s Statens Serum Institut — a government agency that maps the spread of COVID-19 in the country — the Medical Products Agency in Sweden, the National Institute of Public Health in Norway and the Institute for Health and Welfare (THL) in Finland.

The final results are expected in about a month.

In Denmark, children and young people aged12-17 have primarily been invited to receive the COVID-19 vaccine from Pfizer/BioNTech.

“Based on the precautionary principle, we will in future only invite children and young people to receive this vaccine, not least in view of the fact that it is for this vaccine that the largest amount of data from use exists for children and young people, especially from the USA and Israel,” said Bolette Soeborg of the government health agency.

Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume.

Play Video. Duration: 8 minutes 10 seconds

Do we really need booster vaccines for COVID-19?

Moderna’s vaccine was given the green light for use in anyone 18 and over across the 27-nation European Union in January.

It has also been licensed in countries including Britain, Canada and the US, but so far its use hasn’t been extended to children.

Hundreds of millions of Moderna doses already have been administered to adults.

Loading form…

AP



Source link

By EDONS